Valuation : Imexpharm Corporation

Market Cap 5,976B 231M 198M 187M 170M 319M 21.95B 320M 2.21B 856M 11.18B 866M 847M 35.42B P/E 2026 *
16.8x
P/E 2027 * 15.5x
Enterprise Value 5,976B 231M 198M 187M 170M 319M 21.95B 320M 2.21B 856M 11.18B 866M 847M 35.42B EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.07x
Free-Float
6.42%
Yield 2026 *
2.58%
Yield 2027 * 2.58%
1 day+1.70%
1 week-2.51%
Current month-2.51%
1 month+5.72%
3 months-15.65%
6 months-27.75%
Current year-26.10%
1 week 36,650
Extreme 36650
39,400
1 month 35,900
Extreme 35900
41,550
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 31/07/2001
Director of Finance/CFO 52 17/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 31/12/1983
Director/Board Member 50 27/04/2018
Director/Board Member 53 18/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
26/09/22 Buy

Chief Executive Officer

140,000 0.2100%
20/07/22 Sell

Chief Executive Officer

100,000 0.1500%
01/04/22 Exercice

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+1.70%-2.51%-29.33%+28.59% 231M
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 644B
+0.86%-4.13%+19.24%+68.37% 443B
-0.80%-0.43%+28.92%+35.45% 343B
-0.13%-14.97%+9.41%+26.71% 262B
-1.90%-2.72%-2.72%+7.41% 245B
-0.48%-11.65%+39.75%+50.82% 212B
-1.06%-4.23%-14.70%-57.36% 199B
-0.68%-2.65%+25.82%+91.64% 181B
Average -0.34%-4.13%+17.71%+40.97% 352.99B
Weighted average by Cap. -0.42%-3.89%+32.03%+57.16%

Financials

2026 *2027 *
Net sales 2,659B 103M 88.31M 83.15M 75.77M 142M 9.77B 142M 986M 381M 4.98B 385M 377M 15.76B 2,881B 111M 95.68M 90.1M 82.09M 154M 10.58B 154M 1.07B 413M 5.39B 418M 408M 17.08B
Net income 394B 15.21M 13.09M 12.32M 11.23M 21.01M 1.45B 21.09M 146M 56.44M 737M 57.1M 55.86M 2.34B 428B 16.52M 14.21M 13.38M 12.2M 22.82M 1.57B 22.91M 159M 61.31M 801M 62.03M 60.68M 2.54B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
09/09/26 ₫38,800.00 +1.70% 4,346
08/09/26 ₫38,150.00 0.00% 1,446
07/09/26 ₫38,150.00 -1.93% 9,251
04/09/26 ₫38,900.00 -1.27% 4,558
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
38,800.00VND
Average target price
56,000.00VND
Spread / Average Target
+44.33%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!